Sintusek, P.; Buranapraditkun, S.; Khunsri, S.; Saengchaisukhonkit, V.; Vichaiwattana, P.; Srimuan, D.; Thongmee, T.; Poovorawan, Y.
Safety and Humoral and Cellular Immunogenicity of the BNT162b2 SARS-CoV-2 Vaccine in Liver-Transplanted Adolescents Compared to Healthy Adolescents. Vaccines 2022, 10, 1324.
https://doi.org/10.3390/vaccines10081324
AMA Style
Sintusek P, Buranapraditkun S, Khunsri S, Saengchaisukhonkit V, Vichaiwattana P, Srimuan D, Thongmee T, Poovorawan Y.
Safety and Humoral and Cellular Immunogenicity of the BNT162b2 SARS-CoV-2 Vaccine in Liver-Transplanted Adolescents Compared to Healthy Adolescents. Vaccines. 2022; 10(8):1324.
https://doi.org/10.3390/vaccines10081324
Chicago/Turabian Style
Sintusek, Palittiya, Supranee Buranapraditkun, Siriporn Khunsri, Varattaya Saengchaisukhonkit, Preeyaporn Vichaiwattana, Donchida Srimuan, Thanunrat Thongmee, and Yong Poovorawan.
2022. "Safety and Humoral and Cellular Immunogenicity of the BNT162b2 SARS-CoV-2 Vaccine in Liver-Transplanted Adolescents Compared to Healthy Adolescents" Vaccines 10, no. 8: 1324.
https://doi.org/10.3390/vaccines10081324
APA Style
Sintusek, P., Buranapraditkun, S., Khunsri, S., Saengchaisukhonkit, V., Vichaiwattana, P., Srimuan, D., Thongmee, T., & Poovorawan, Y.
(2022). Safety and Humoral and Cellular Immunogenicity of the BNT162b2 SARS-CoV-2 Vaccine in Liver-Transplanted Adolescents Compared to Healthy Adolescents. Vaccines, 10(8), 1324.
https://doi.org/10.3390/vaccines10081324